Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31047937 | 0.70 | ALDH1A1 (0.31) | ALDH1A1HPGD | |
| SCHEMBL28816642 | 0.70 | — | — | |
| SCHEMBL17632593 | 0.66 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL4707103 | 0.65 | PARP1 (0.35) | ALDH1A1HPGD | |
| SCHEMBL20538688 | 0.65 | KDM4E (0.31) | — | |
| Methane SCHEMBL28807375 | 0.64 | ALDH1A1 (0.31) | ALDH1A1HPGD | |
| SCHEMBL31231875 | 0.63 | CA2 (0.30) | — | |
| SCHEMBL27813944 | 0.63 | — | — | |
| SCHEMBL28933369 | 0.62 | MEN1 (0.40) | ALDH1A1HPGD | |
| SCHEMBL28474113 | 0.61 | ALDH1A1 (0.38) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100016319-A1 | ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF | TORAY INDUSTRIES, INC. A CORPORATION OF JAPAN (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-1970375-A1 | ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016319-A1 | ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF | UROD, UTS2R, SLC14A1 | ALDH1A1 250/4885HPGD 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.